COVID-19 Patients with Pulmonary Fibrotic Tissue: Clinical Pharmacological Rational of Antifibrotic Therapy
Crossref DOI link: https://doi.org/10.1007/s42399-020-00487-7
Published Online: 2020-08-27
Published Print: 2020-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Vitiello, Antonio
Pelliccia, Chiara
Ferrara, Francesco http://orcid.org/0000-0001-9298-6783
Text and Data Mining valid from 2020-08-27
Version of Record valid from 2020-08-27
Article History
Accepted: 24 August 2020
First Online: 27 August 2020
Compliance with Ethical Standards
:
: The authors declare that they have no conflict of interest.
Free to read: This content has been made available to all.